Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577251 · ClinicalTrials.gov registry record
The Radiation Oncology Registry and Biosample Repository
A clinical trial of Neoplasia, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- 8,000
- Enrollment target
- 4
- Study locations
NCT01577251 is a study of Neoplasia that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 8,000 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT01577251, a study of Neoplasia, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- 8,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
Conditions Studied
Study Locations (4)
New Jersey
- Virtua Samson Cancer Center - Moorestown
- Virtua Health & Wellness Center - Voorhees Township
Pennsylvania
- Lancaster General Hospital - Lancaster
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2008-06 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01577251
The ClinicalTrials.gov registry entry for NCT01577251 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01577251 reports 4 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01577251 about?
NCT01577251 is a clinical study titled "The Radiation Oncology Registry and Biosample Repository". The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
What is the current status of trial NCT01577251?
This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2008-06. Estimated completion is 2030-12.
What conditions does trial NCT01577251 study?
This clinical trial studies the following conditions: Neoplasia.
Who is sponsoring clinical trial NCT01577251?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01577251 being conducted?
This trial has 4 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.